Cardiff Oncology
CRDF
CRDF
87 hedge funds and large institutions have $132M invested in Cardiff Oncology in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 94 → 87 (-7)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
34% less call options, than puts
Call options by funds: $895K | Put options by funds: $1.36M
Holders
87
Holding in Top 10
1
Calls
$895K
Puts
$1.36M
Top Buyers
| 1 | +$3.02M | |
| 2 | +$2.66M | |
| 3 | +$1.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$877K |
| 5 |
BlackRock
New York
|
+$868K |
Top Sellers
| 1 | -$4.28M | |
| 2 | -$1.37M | |
| 3 | -$403K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$292K |
| 5 |
Two Sigma Advisers
New York
|
-$215K |